102 related articles for article (PubMed ID: 16353344)
1. Paraoxonase (PON1): from toxicology to cardiovascular medicine.
Costa LG; Cole TB; Furlong CE
Acta Biomed; 2005; 76 Suppl 2():50-7. PubMed ID: 16353344
[TBL] [Abstract][Full Text] [Related]
2. Measurement of paraoxonase (PON1) status as a potential biomarker of susceptibility to organophosphate toxicity.
Costa LG; Cole TB; Vitalone A; Furlong CE
Clin Chim Acta; 2005 Feb; 352(1-2):37-47. PubMed ID: 15653099
[TBL] [Abstract][Full Text] [Related]
3. Modulation of paraoxonase (PON1) activity.
Costa LG; Vitalone A; Cole TB; Furlong CE
Biochem Pharmacol; 2005 Feb; 69(4):541-50. PubMed ID: 15670573
[TBL] [Abstract][Full Text] [Related]
4. Paraoxonase (PON1) polymorphism and activity as the determinants of sensitivity to organophosphates in human subjects.
Sirivarasai J; Kaojarern S; Yoovathaworn K; Sura T
Chem Biol Interact; 2007 Jul; 168(3):184-92. PubMed ID: 17532308
[TBL] [Abstract][Full Text] [Related]
5. Relationship between human paraoxonase-1 activity and PON1 polymorphisms in Mexican workers exposed to organophosphate pesticides.
López-Flores I; Lacasaña M; Blanco-Muñoz J; Aguilar-Garduño C; Sanchez-Villegas P; Pérez-Méndez OA; Gamboa-Avila R
Toxicol Lett; 2009 Jul; 188(2):84-90. PubMed ID: 19446239
[TBL] [Abstract][Full Text] [Related]
6. A gene-environment study of the paraoxonase 1 gene and pesticides in amyotrophic lateral sclerosis.
Morahan JM; Yu B; Trent RJ; Pamphlett R
Neurotoxicology; 2007 May; 28(3):532-40. PubMed ID: 17204329
[TBL] [Abstract][Full Text] [Related]
7. Paraoxonase 1 (PON1) organophosphate hydrolysis is not reduced in ALS.
Wills AM; Landers JE; Zhang H; Richter RJ; Caraganis AJ; Cudkowicz ME; Furlong CE; Brown RH
Neurology; 2008 Mar; 70(12):929-34. PubMed ID: 18347314
[TBL] [Abstract][Full Text] [Related]
8. Defective metabolism of oxidized phospholipid by HDL from people with type 2 diabetes.
Mastorikou M; Mackness M; Mackness B
Diabetes; 2006 Nov; 55(11):3099-103. PubMed ID: 17065348
[TBL] [Abstract][Full Text] [Related]
9. Maternal exposure to floricultural work during pregnancy, PON1 Q192R polymorphisms and the risk of low birth weight.
Moreno-Banda G; Blanco-Muñoz J; Lacasaña M; Rothenberg SJ; Aguilar-Garduño C; Gamboa R; Pérez-Méndez O
Sci Total Environ; 2009 Oct; 407(21):5478-85. PubMed ID: 19646734
[TBL] [Abstract][Full Text] [Related]
10. Paraoxonase/arylesterase ratio, PON1 192Q/R polymorphism and PON1 status are associated with increased risk of ischemic stroke.
Can Demirdöğen B; Türkanoğlu A; Bek S; Sanisoğlu Y; Demirkaya S; Vural O; Arinç E; Adali O
Clin Biochem; 2008 Jan; 41(1-2):1-9. PubMed ID: 17920578
[TBL] [Abstract][Full Text] [Related]
11. The Relationship between PON1 phenotype and PON1-192 genotype in detoxification of three oxons by human liver.
Mutch E; Daly AK; Williams FM
Drug Metab Dispos; 2007 Feb; 35(2):315-20. PubMed ID: 17132760
[TBL] [Abstract][Full Text] [Related]
12. Distribution of paraoxonase-1 gene polymorphisms and enzyme activity in a Peruvian population.
Cataño HC; Cueva JL; Cardenas AM; Izaguirre V; Zavaleta AI; Carranza E; Hernández AF
Environ Mol Mutagen; 2006 Dec; 47(9):699-706. PubMed ID: 17078098
[TBL] [Abstract][Full Text] [Related]
13. Human paraoxonase gene polymorphisms and coronary artery disease risk.
Mendonça MI; Dos Reis RP; Freitas AI; Sousa AC; Pereira A; Faria P; Gomes S; Silva B; Santos N; Serrão M; Ornelas I; Freitas S; Araújo JJ; Brehm A; Cardoso AA
Rev Port Cardiol; 2008 Dec; 27(12):1539-55. PubMed ID: 19280995
[TBL] [Abstract][Full Text] [Related]
14. [Relationship between paraoxonase 1 55 Met/Leu, paraoxonase 2 148 Ala/Gly genetic polymorphisms and coronary artery disease].
Chi DS; Ling WH; Ma J; Xia M; Hou MJ; Wang Q; Zhu HL; Tang ZH; Yu XP
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Jun; 23(3):289-93. PubMed ID: 16767666
[TBL] [Abstract][Full Text] [Related]
15. [Human plasma paraoxonase (HuPON1): an anti-atherogenic enzyme with organophosphate hydrolase activity].
Josse D; Masson P
Ann Pharm Fr; 2001 Apr; 59(2):108-18. PubMed ID: 11320335
[TBL] [Abstract][Full Text] [Related]
16. Paraoxonase-1 does not reduce or modify oxidation of phospholipids by peroxynitrite.
Connelly PW; Draganov D; Maguire GF
Free Radic Biol Med; 2005 Jan; 38(2):164-74. PubMed ID: 15607900
[TBL] [Abstract][Full Text] [Related]
17. Discordance in human paraoxonase-1 gene between phenotypes and genotypes in chronic kidney disease.
Paragh G; Seres I; Harangi M; Pocsai Z; Asztalos L; Locsey L; Szeles G; Kardos L; Varga E; Karpati I; Adany R
Nephron Clin Pract; 2009; 113(1):c46-53. PubMed ID: 19602899
[TBL] [Abstract][Full Text] [Related]
18. The role of paraoxonase polymorphisms in the induction of micronucleus in paraoxon-treated human lymphocytes.
Rojas-García AE; Sordo M; Vega L; Quintanilla-Vega B; Solis-Heredia M; Ostrosky-Wegman P
Environ Mol Mutagen; 2009 Dec; 50(9):823-9. PubMed ID: 19402156
[TBL] [Abstract][Full Text] [Related]
19. PON1 activity and genotype in patients with arterial ischemic stroke and in healthy individuals.
Schiavon R; Turazzini M; De Fanti E; Battaglia P; Targa L; Del Colle R; Fasolin A; Silvestri M; Biasioli S; Guidi G
Acta Neurol Scand; 2007 Jul; 116(1):26-30. PubMed ID: 17587252
[TBL] [Abstract][Full Text] [Related]
20. Relationship of serum paraoxonase 1 activity and paraoxonase 1 genotype to risk of systemic lupus erythematosus.
Tripi LM; Manzi S; Chen Q; Kenney M; Shaw P; Kao A; Bontempo F; Kammerer C; Kamboh MI
Arthritis Rheum; 2006 Jun; 54(6):1928-39. PubMed ID: 16729301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
